The Pharmacy Times® Immunization Resource Center is a comprehensive resource for clinical news and expert insights on common immunizations, such as flu, zoster, and COVID-19 vaccines.
October 28th 2024
Champions for Vaccine Education, Equity, and Progress reported that the majority of pharmacists believe that it is important to prioritize vaccine development and distribution.
Influenza Prevention in the At-Risk Adult Population and the Pharmacist's Role in an Evolving Influenza Vaccin...
1.25 Credits / Immunization, Infectious Diseases
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Pneumococcal Disease Prevention for Older Adults and the Pharmacist’s Role in an Evolving Vaccine Landscape
1.0 Credit / Immunization, Infectious Diseases
View More
Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Ac...
1.5 Credits / HIV/AIDS, Infectious Diseases
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
Pregnant Women at Higher Risk for Influenza-Associated Hospitalization
February 18th 2019Writing in The Journal of Infectious Disease, they noted that pregnant women tend to be treated as high-priority patients when it comes to influenza prevention and treatment, but they said there is relatively little evidence clarifying exactly how outcomes differ for pregnant women versus nonpregnant women.
Read More
Report Links Hepatitis A Outbreaks in Certain States to Drug Use, Homelessness
November 12th 2018A new report published in the CDC Morbidity and Mortality Weekly Report (MMWR) has linked cases of acute hepatitis A virus (HAV) infections from certain states to person-to-person transmission from drug use or homelessness.
Read More
First New Antiviral for Influenza in 2 Decades Approved by FDA
October 24th 2018Officials with the FDA have approved baloxavir marboxil (Xofluza, Shionogi) for the treatment of acute uncomplicated influenza in patients aged 12 years and older who have been symptomatic for no more than 48 hours.
Read More
New Data Show Efficacy of Combo Therapy Elbasvir/Grazoprevir for Hepatitis C
October 3rd 2018A new review of clinical trial data show the combination therapy elbasvir/grazoprevir (EBR/GR) has high rates of efficacy for patients with genotypes 1a, 1b, and 4 chronic hepatitis C (HCV) infection.
Read More
Dispensing Medications and Offering Vaccinations: How Brown Bagging Can Bring Clarity
October 3rd 2018Brown-bag consults can be essential educational and safety tools to measure and ensure quality care. By asking patients to bring in all their current medications, including OTC, mail-order, specialty, and herbal products, pharmacists can guarantee appropriate and up-to-date care.
Read More